数据链接：
官方服务：
资源简介：
First line therapy as per primary cause of bleeding.
应用场景：
创建时间：
2017-11-07
相关数据集
Supplementary Material for: Influence of Frailty and Life Expectancy on Guideline Adherence and Outcomes in Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Prospective Pilot Study
Background: Cutaneous squamous cell carcinoma is the second most common malignancy of the skin, often occurring in older patients and in the head and neck area (cSCCHN). Age, life expectancy, and frai
karger.figshare.com2023-06-02 更新130
Data_Sheet_1_Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey.PDF
Background: Pulmonary hypertension is a complication of chronic lung diseases (PH-CLD) associated with significant morbidity and mortality. Management guidelines for PH-CLD emphasize the treatment of
NIAID Data Ecosystem40
A Study of ChemoFx Chemoresponse Assay in Solid Tumors - ChemoFx Registry Study
The purpose of this research study is to collect information from patient’s medical records that had a test called ChemoFx ordered and to understand how doctors may have used the results of the ChemoF
NIAID Data Ecosystem30
Bleeding management after implementation of the Hemorrhage Code (Code H) at the Hospital Israelita Albert Einstein, São Paulo, Brazil
ABSTRACT Objective To describe the implementation of a care protocol based on rapid response teams, for management and resolution of bleeding. Methods A hospital protocol called Hemorrhage Code (Code
DataCite Commons2021-03-26 更新40
Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model
Introduction Increasing use of factor Xa (FXa) inhibitors necessitates effective reversal agents to manage bleeding. Andexanet alfa, a novel modified recombinant human FXa, rapidly reverses the antico
NIAID Data Ecosystem30
